Evaluation of Skin Health and Quality of Life in Patients Receiving Anti-PD1/PDL1/CTLA4 or Cyclin-dependent Kinase (CDK) Inhibitors.
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL
Conditions: Lung Cancer|Breast Cancer|Kidney Cancer|Bladder Cancer|Gastric Cancer|Skin Cancer|Melanoma|Head Neck Cancer
Interventions: OTHER: EQ-5D-5L questionnaire|OTHER: FACT-G (Functional Assessment of Cancer Therapy - General)|OTHER: FACT-EGFRI-18 (Functional Assessment of Cancer Therapy - Epidermal Growth Factor Inhibitors 18 Item)
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS